There’s information. And then there’s intelligence.

PharmSource’s accurate, insightful Trend Reports provide context and meaning that’s critical to decision-makers in the bio/pharma contract services arena. Our experts identify trends and forecast changes – delivering the knowledge and understanding necessary to achieve optimal strategic outcomes.

CMO Market Penetration as Evidenced by Outsourced NDA Approvals

This annual Market Intelligence Briefing examines NDA activity as an indicator of global bio/pharma outsourcing behavior by analyzing NDA approvals for the prior year and approval trends for the most recent 5-year period. In this year’s edition, we see contract manufacturing trends that…

Learn more

Webinar – Mixed Signals

This on-demand webinar provides valuable insight into what’s driving R&D spending and whether those changes bode well for contract services providers. PharmSource president Jim Miller delivers…

Learn more

The Demand and Supply for Contract Manufacturing of
Conventional Injectable Drugs Through 2019

This extensive study analyzes and estimates the demand and supply for contract injectable manufacturing through 2019. It covers the latest trends for outsourcing of commercially approved injectable products by the major pharmaceutical and bio/pharmaceutical companies, and includes a companion study on contract cytotoxic injectable drugs…

Learn more

NDA Review:
CMOs Tread Water

This PharmSource analysis gives critical insight into evolving contract manufacturing trends and developments, and provides an in-depth data-driven analysis, giving a “who’s who” of…

Learn more